Ident. | Authors (with country if any) | Title |
---|
000095 |
R. Djidjou-Demasse [France] ; Y. Michalakis ; M. Choisy ; M. T. Sofonea ; S. Alizon | Optimal COVID-19 epidemic control until vaccine deployment |
000188 |
Claire Rousset [France] | Coevolution of the HIV envelope glycoproteins and broadly neutralizing antibodies targeting the N332 glycan region |
000194 |
Emilie Bayon [France] ; Jessica Morlieras [France] ; Nathalie Dereuddre-Bosquet [France] ; Alexis Gonon [France] ; Leslie Gosse [France] ; Thomas Courant [France] ; Roger Le Grand [France] ; Patrice Marche [France] ; Fabrice Navarro [France] | Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates |
000353 |
Mélissanne De Wispelaere [France] ; Meret Ricklin [Suisse] ; Philippe Souque [France] ; Marie-Pascale Frenkiel [France] ; Sylvie Paulous [France] ; Obdulio Garcìa-Nicolàs [Suisse] ; Artur Summerfield [Suisse] ; Pierre Charneau [France] ; Philippe Desprès [France] | A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs |
000381 |
Sophie Massin [France] ; Bruno Ventelou [France] ; Antoine Nebout-Javal [France] ; Pierre Verger [France] ; Céline Pulcini [France] | Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination |
000448 |
Michael Pfleiderer [Allemagne] ; Jean-Hugues Trouvin [France] ; Daniel Brasseur [Belgique] ; Marta Gr Nstrom [Suède] ; Ragini Shivji [Royaume-Uni] ; Manuela Mura [Royaume-Uni] ; Marco Cavaleri [Royaume-Uni] | Summary of knowledge gaps related to quality and efficacy of current influenza vaccines |
000455 |
O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France] | Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis |
000458 |
Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France] | Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients |
000531 |
J. Haensler [France] | Introduction aux nouveaux adjuvants vaccinaux et à leur rôle dans la vaccination antigrippale |
000537 |
Yves Dauvilliers [France] ; Isabelle Arnulf [France] ; Michel Lecendreux [France] ; Christelle Monaca Charley [France] ; Patricia Franco [France] ; Xavier Drouot [France] ; Marie-Pia D'Ortho [France] ; Sandrine Launois [France] ; Séverine Lignot [France] ; Patrice Bourgin [France] ; Béatrice Nogues [France] ; Marc Rey [France] ; Sophie Bayard [France] ; Sabine Scholz [France] ; Sophie Lavault [France] ; Pascale Tubert-Bitter [France] ; Cristel Saussier [France] ; Antoine Pariente [France] | Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France |
000538 |
Carlos A. Diazgranados [États-Unis] ; Andrew J. Dunning [États-Unis] ; Emilia Jordanov [États-Unis] ; Victoria Landolfi [États-Unis] ; Martine Denis [France] ; H. Keipp Talbot [États-Unis] | High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season |
000540 |
Céline Pulcini [France] ; Sophie Massin [France] ; Odile Launay [France] ; Pierre Verger [France] | Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey |
000544 |
R. G. Pebody [Royaume-Uni] ; N. Andrews [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; J. Mcmenamin [Royaume-Uni] ; S. Cottrell [Royaume-Uni] ; B. Smyth [Royaume-Uni] ; H. Durnall [Royaume-Uni] ; C. Robertson [Royaume-Uni, France] ; W. Carman [Royaume-Uni] ; J. Ellis [Royaume-Uni] ; P. Sebastian-Pillai [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; C. Kearns [Royaume-Uni] ; C. Moore [Royaume-Uni] ; D. Rh. Thomas [Royaume-Uni] ; J. M. Watson [Royaume-Uni] | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom |
000545 |
Barry D. Schoub [Afrique du Sud] ; Bradford D. Gessner [France] ; William Ampofo [Ghana] ; Adam L. Cohen [Afrique du Sud, États-Unis] ; Christoph A. Steffen [France] | Afriflu2-Second international workshop on influenza vaccination in the African continent-8 November 2012, Cape Town (South Africa) |
000608 |
Mélanie Moltenis [France] ; Marie-Blanche Valnet-Rabier [France] ; Joël Leroy [France] ; Jean-Pierre Kantelip [France] | Point sur les vaccinations à risque pendant la grossesse |
000617 |
Emmanuel Grimprel [France] | Nouveautés vaccinales en médecine humaine : Vaccins humains, vaccins vétérinaires, même combat |
000631 |
B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France] | Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study |
000633 |
M. Valenciano [France] ; B. C. Ciancio [Suède] | I-MOVE: a European network to measure the effectiveness of influenza vaccines |
000635 |
I. Bonmarin [France] ; E. Belchior [France] ; Y. Le Strat [France] ; D. Levy-Bruhl [France] | First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12 |
000636 |
Geneviève Durrieu [France] ; Aurore Palmaro [France] ; Laure Pourcel [France] ; Céline Caillet [France] ; Angeline Faucher [France] ; Alexis Jacquet [France] ; Shéhérazade Ouaret [France] ; Marie Christine Perault-Pochat [France] ; Carmen Kreft-Jais [France] ; Anne Castot [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] | First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines: A Comparison of Reports Submitted by Patients and Healthcare Professionals |
000638 |
Colin R. Simpson [Royaume-Uni] ; Lewis D. Ritchie [Royaume-Uni] ; Chris Robertson [Royaume-Uni, France] ; Aziz Sheikh [Royaume-Uni] ; Jim Mcmenamin [Royaume-Uni] | Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study |
000639 |
E. Kissling [France] ; M. Valenciano [France] | Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12 |
000718 |
Catherine Weil-Olivier [France] ; Bruno Lina [France] | Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season |
000722 |
Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux [France] ; Jade Ghosn [France] ; François Raffi [France] ; David Rey [France] ; Faiza Ajana [France] ; Nathalie Colin De Verdiere [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman [Belgique] ; Jeanne-Marie Devaster [Belgique] ; Jean-Frangois Delfraissy [France] ; Jean-Pierre Aboulker [France] | Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial |
000729 |
E. Omon [France] ; C. Damase-Michel [France] ; C. Hurault-Delarue [France] ; I. Lacroix [France] ; J. L. Montastruc [France] ; S. Oustric [France] ; B. Escourrou [France] | Non-adjuvanted 2009 influenza A (H1N1 )v vaccine in pregnant women: The results of a French prospective descriptive study |
000730 |
Vassilis Tsatsaris [France] ; Catherine Capitant ; Thomas Schmitz ; Corine Chazallon ; Sophie Bulifon ; Didier Riethmuller ; Olivier Picone ; Patrice Poulain ; Fanny Lewin ; Fabrice Laine ; Evelyne Jacqz-Aigrain ; Jean-Pierre Aboulker ; Odile Launay | Maternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine: A Single-Group Trial |
000733 |
L. Cotte [France] ; N. Voirin [France] ; C. Richard [France] ; C. Brochier [France] ; I. Schlienger [France] ; P. Lack [France] ; B. Lina [France] ; P. Vanhems [France] ; F. Zoulim [France] | Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients |
000737 |
Ida Rosenkrands [Danemark] ; Carina Vingsbo-Lundberg [Danemark] ; Trine Junker Bundgaard [Danemark] ; Thomas Lindenstr M [Danemark] ; Vincent Enouf [France] ; Sylvie Van Der Werf [France] ; Peter Andersen [Danemark] ; Else Marie Agger [Danemark] | Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes |
000738 |
Emilie Javelle [France] ; Benjamin Soulier ; Christian Brosset ; Solène Lorcy [France] ; Fabrice Simon [France] | Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine |
000742 |
Aurelie Mayet [France] ; Caroline Ligier [France] ; Kristel Gache [France] ; Ghislain Manet [France] ; Philippe Nivoix [France] ; Aissata Dia [France] ; Rachel Haus-Cheymol [France] ; Catherine Verret [France] ; Sandrine Duron [France] ; Nina Faure [France] ; Martine Piarroux [France] ; Frank De Laval [France] ; Fabrice Simon [France] ; Christophe Decam [France] ; Herve Chaudet [France] ; Jean-Baptiste Meynard [France] ; Christophe Rapp [France] ; Xavier Deparis [France] ; Rene Migliani [France] | Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces-2009-2010 |
000802 |
Catherine Weil-Olivier [France] | Vaccination contre la grippe A/HINIv 2009 |
000803 |
F. Bricaire [France] | Vaccination antigrippe A (H 1 N 1 ): analyse rétrospective 2009 |
000808 |
Alexis Jacquet [France] ; Shéhérazade Ouaret [France] ; Carmen Kreft-Jaïs [France] ; Anne Castot [France] | Suivi national de pharmacovigilance des vaccins pandémiques A(H1N1): premiers résultats : Vaccinations |
000811 |
S. Bulifon [France] ; V. Tsatsaris [France] ; F. Goffinet [France] ; A. Mignon [France] ; F. Batteux [France] ; J.-F. Delfraissy [France] ; O. Launay [France] | Pandémie grippale A/H1N1v, grossesse et vaccination |
000815 |
S. Abbes [France] | Infectiologie |
000819 |
F. Mahassin [France] ; S. Jaureguiberry [France] ; G. Monsel [France] ; E. Caumes [France] ; F. Bricaire [France] | Grippe A (H1N1) 2009. Revue générale |
000822 |
Marc P. Girard [France] | DU PORC À L'HOMME: LA PANDÉMIE DE GRIPPE A (H1 N1) 2009 |
000823 |
Pierre Begue [France] ; Bernard Salle | Conséquences des oppositions vaccinales en France et en Europe.: Comment maintenir une couverture vaccinale efficace en 2010 ? Discussion |
000826 |
Marc P. Girard [France] ; John S. Tam [Suisse] ; Olga M. Assossou [France] ; Marie Paule Kieny [Suisse] | The 2009 A (H1N1 ) influenza virus pandemic: A review |
000836 |
Ana Canestri [France] ; Anne Krivine [France] ; Lambert Assoumou [France] ; Monique Le Corre [France] ; Flore Rozenberg [France] ; Anne-Geneviève Marcelin [France] ; Luminita Schneider [France] ; Assia Samri [France] ; Guislaine Carcelain [France] ; Brigitte Autran [France] ; Christine Katlama [France] ; Amélie Guihot [France] | Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients |
000840 |
Koert J. Stittelaar [Pays-Bas] ; Valérie Lacombe [France] ; Rob Van Lavieren [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; James Simon [Pays-Bas] ; Valérie Cozette [France] ; David E. Swayne [États-Unis] ; Hervé Poulet [France] ; Albert D. M. E. Osterhaus [Pays-Bas] | Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine |
000843 |
Catherine Caillet [France] ; Fabienne Piras [France] ; Marie-Clotilde Bernard [France] ; Aymeric De Montfort [France] ; Florence Boudet [France] ; Frederick R. Vogel [France] ; Agnès Hoffenbach [France] ; Catherine Moste [France] ; Inca Kusters [France] | AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice |
000852 |
Corinne Bergeron [France] | Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses |
000886 |
Pierre Loulergue [France] ; Odile Launay [France] | Vaccins pandémiques et prépandémiques dirigés contre le virus grippal H5N1 |
000917 |
Rebecca J. Cox [Norvège] ; Abdullah S. Madhun [Norvège] ; Solveig Hauge [Norvège] ; Haakon Sjursen [Norvège] ; Diane Major [Royaume-Uni] ; Mirjam Kuhne [Royaume-Uni] ; Katja Höschler [Royaume-Uni] ; Melanie Saville [France] ; Frederick R. Vogel [France] ; Wendy Barclay [Royaume-Uni] ; Isabella Donatelli [Italie] ; Maria Zambon [Royaume-Uni] ; John Wood [Royaume-Uni] ; Lars R. Haaheim [Norvège] | A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine |
000919 |
E. Kissling [France] ; M. Valenciano [France] ; J. M. Falcao [Portugal] ; A. Larrauri [Espagne] ; K. Widgren [Danemark, Suède] ; D. Pitigoi [Roumanie] ; B. Oroszi [Hongrie] ; B. Nunes [Portugal] ; C. Savulescu [Espagne, Suède] ; A. Mazick [Danemark] ; E. Lupulescu [Roumanie] ; B. Ciancio [Suède] ; A. Moren [France] | "I-MOVE" TOWARDS MONITORING SEASONAL AND PANDEMIC INFLUENZA VACCINE EFFECTIVENESS: LESSONS LEARNT FROM A PILOT MULTI-CENTRIC CASE-CONTROL STUDY IN EUROPE, 2008-9 |
000969 |
Hans C. Rümke [Pays-Bas] ; José-Maria Bayas [Espagne] ; José-Ramon De Juanes [Espagne] ; Covadonga Caso [Espagne] ; Jan Hendrik Richardus [Pays-Bas] ; Magda Campins [Espagne] ; Lars Rombo [Suède] ; Xavier Duval [France] ; Viktor Romanenko [Russie] ; Tino F. Schwarz [Allemagne] ; Rustem Fassakhov [Russie] ; Francisco Abad-Santos [Espagne] ; Frank Von Sonnenburg [Allemagne] ; Mamadou Drame [Belgique] ; Roland S Nger [Belgique] ; W. Ripley Ballou [Belgique] | Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial |
000971 |
Marc-André D'Aoust [Canada] ; Pierre-Olivier Lavoie [Canada] ; Manon M.-J. Couture [Canada] ; Sonia Trepanier [Canada] ; Jean-Martin Guay [Canada] ; Michèle Dargis [Canada] ; Sébastien Mongrand [France] ; Nathalie Landry [Canada] ; Brian J. Ward [Canada] ; Louis-P. Vezina [Canada] | Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice |
000972 |
Thierry Van Den Berg [Belgique] ; Bénédicte Lambrecht [Belgique] ; Sylvie Marche [Belgique] ; Mieke Steensels [Belgique] ; Steven Van Borm [Belgique] ; Michel Bublot [France] | Influenza vaccines and vaccination strategies in birds |
000973 |
M. Vatenciano [France] ; B. C. Ciancio [Suède] ; Alain Moren [France] | First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States : Influenza |
000975 |
Gregory A. Poland [États-Unis] ; Suryaprakash Sambhara [États-Unis] ; Karin Levie [Belgique] ; Isabel Leroux-Roels [Belgique] ; Karel Hoppenbrouwers [Belgique] ; Anne-Diane Kervyn [Belgique] ; Corinne Vandermeulen [Belgique] ; Sheron Forgus [Belgique] ; Geert Leroux-Roels [Belgique] ; Sylvie Pichon [France] ; Inca Kusters [France] | An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. Commentary |
000995 |
A. Haque [États-Unis] ; B. Lucas [France] ; D. Hober [France] | Menace liée au virus influenza A/H5N1 et mise en place de la prévention face à un risque de pandémie de grippe |
000A02 |
F. Carrat [France] ; A. Flahault [France] | Influenza vaccine : The challenge of antigenic drift |
000A37 |
Maurice-Paul Durand [France] | Les solutions vaccinales chez l'homme et l'animal face aux virus influenza aviaire H5N1 |
000A41 |
Pierre Loulergue [France] | H5N1 : menace pandémique et perspectives vaccinales |
000A44 |
N. Naffakh [France] ; E. A. Dos Santos [France] ; N. Escriou [France] ; S. Van Der Werf [France] | Développement et applications de la génétique inverse des virus grippaux |
000A46 |
Antoine Flahault [France] ; Elisabeta Vergu [France] ; Laurent Coudeville [France] ; Rebecca F. Grais [France] | Strategies for containing a global influenza pandemic |
000A55 |
F. Bricaire [France] ; J. P. Derenne [France] | Grippe aviaire |
000A57 |
Marc P. Girard [France] ; Thomas Cherian [Suisse] ; Yuri Pervikov [Suisse] ; Marie Paule Kieny [Suisse] | A review of vaccine research and development : Human acute respiratory infections |
000A66 |
Michel Bublot [France] | Les grippes aviaires, une menace permanente |
000A68 |
Jean Guenel [France] | La grippe "espagnole" en France en 1918-1919 |
000A69 |
David S. Fedson [France] | Vaccination for pandemic influenza: a six point agenda for interpandemic years |
000A71 |
David S. Fedson [France] | Pandemic Influenza and the Global Vaccine Supply |
000A78 |
G. A. Van Essen [Pays-Bas] ; A. M. Palache [Pays-Bas] ; E. Forleo [Brésil] ; D. S. Fedson [France] | Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries |
000A84 |
C. Hannoun [France] | La grippe espagnole (1818-1919) : un accident dans l'histoire ? |
000A91 |
J. Gaillat [France] | Que penser du traitement antiviral de la grippe en l'an 2001 ? |
000B01 |
M. Aymard [France] ; L. Gerentes [France] ; N. Kessler [France] | Place des anticorps antineuraminidase dans la protection contre la grippe |
000B05 |
M. Aymard [France] ; L. Gerentes ; N. Kessler ; C. Pilet ; G. Blancher ; J.-C. Sournia ; E. Aron ; C. Laverdant ; L. Le Minor | Place des anticorps antineuraminidase dans la protection contre la grippe. Discussion |